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We have been studying a population of bipotential glial progenitor 
cells in the perinatal rat optic nerve and brain in an attempt to 
understand how cells choose between alternative fates in the 
developing mammalian central nervous system (CNS). This cell 
population gives rise initially to oligodendrocytes and then to 
type-2 astrocytes\ both of which apparently collaborate in sheath-
ing axons in the CNS2.3. In vitro studies suggest that oligoden-
drocyte differentiation is the constitutive pathway of development 
for the oligodendrocyte-type-2-astrocyte (O-2A) progenitor ce1l4,s, 
whereas type-2 astrocyte differentiation depends on a specific 
inducing protein6. This protein is present in the developing optic 
nerve when type-2 astrocytes are differentiating and can induce 
0-2A progenitor cells in vitro to express glial fibrillary acidic 
protein (GFAP)6, a marker of astrocyte differentiation'. Here we 
show that the type-2-astrocyte-inducing protein is similar or iden-
tical to ciliary neutrotrophic factor (CNTF)8,9, which promotes 
the survival of some types of peripheral neurons in vitro8, including 
ciliary ganglion neurons8,IO. This suggests that CNTF, in addition 
to its effect on neurons, may be responsible for triggering type-2 
astrocyte differentiation in the developing CNS. 
CNTF was purified from rat sciatic nerve using a modification 
of the method used previousll. When it was added to cultures 
of postnatal-day-O (PO) rat optic nerve cells it induced GFAP 
expression in about 20% of 0-2A progenitor cells (Fig. la). 
The same result was obtained with an extract of 3-4-week-old 
rat optic nerve (Fig. Ib), as described previously6. CNTF and 
optic nerve extract had the same effect when added simul-
taneously as when either was added alone (Fig. lb). Two other 
neurotrophic factors, nerve growth factorl1,12 and brain-derived 
growth factor13, had no effect on GFAP expression in this assay 
(not shown). 
CNTF and the type-2-astrocyte-inducing protein share several 
properties. They are both acidic (ref. 9 and unpublished observa-
tions), with a relative molecular mass (Mr) of about 25,000 
(25K) (refs 6 and 9), and present at relatively high concentrations 
in sciatic nerve6 ,l4 and kidney (ref. 9 and unpublished observa-
tions), compared with liver, retina or brain (refs 6, 14 and 
unpublished observations). If the type-2-astrocyte-inducing 
activity in optic nerve extracts is CNTF, then these extracts 
should support ciliary ganglion neuron survival in vitro, which 
they did (Fig. Id). The responses of both ciliary ganglion 
neurons and 0-2A progenitor cells were elicited within a similar 
range of concentrations (Fig. 1); the specific activity of optic 
nerve extract was about 1,300-fold less than that of CNTF in 
both assays. 
When tested on optic nerve cells CNTF had many of the 
functional properties previously described for optic nerve 
extract6• First, CNTF had no appreciable effect on GFAP 
expression in type-l astrocytes or their precursors in cultures 
of embryonic day 17 (E17) optic nerve cells, even though it 
induced many of the 0-2A progenitor cells in such cultures to 
express GFAP (not shown). Second, unlike fetal calf serum 
(FCS), which is also an inducer of type-2 astrocyte differenti-
t Present address: Department of Pharmacology. Stanford University Medical School, Stanford. 
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Table I The GFAP-inducing effect ofCNTF is transient and decreases 
with increasing age of optic nerve 
% 0-2A progenitor cells expressing GFAP 
With optic 
Age of Days With CNTF nerve extract With 
rats in vitro (1-4 ng ml-
'
) (2 ILgml-
'
) neither 
EI8 35±2 30±4 0 
PO I 21 ±5 19±4 0 
P7 1 9±5 8±4 0.2±O.5 
PO 1 18±7 18±5 0 
PO 3 0 0 0 
Optic nerve cells were prepared, cultured, and assayed as described 
in Fig.!. Results are expressed as mean ±standard deviation of at least 
three cultures. 
ation in vitrot, CNTF induced only a proportion of 0-2A pro-
genitor cells in optic nerve to express GFAP, and this proportion 
decreased with increasing age from EI8 to P7 (Table 1). Third, 
and again unlike FCS, CNTF caused only transient GFAP 
expression in 0-2A progenitor cells, even when added daily: 
the response was maximal by 1 day and gone by 3 days (Table 
1). This suggests that CNTF can initiate type-2 astrocyte 
differentiation but cannot on its own induce 0-2A progenitor 
cells to complete the process. Both the age-dependence and 
transient nature of the response are discussed elsewhere (ref. 6 
and L.E.L. and M.C.R., in preparation). 
The type-2-astrocyte-inducing activity in optic nerve extract 
co-migrated with purified CNTF on SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) (Fig. 2). When an extract of 3-4-
week-old rat optic nerve was submitted to the same purification 
procedure used to obtain sequence-pure CNTF from rat sciatic 
nerve extract, several polypeptides of Mr = 25K were obtained. 
This semi-purified preparation from optic nerve had type-2-
astrocyte-inducing activity and promoted ciliary ganglion 
neuron survival (Fig. 3), and the specific activity was about 
IO-fold less than that of CNTF purified from sciatic nerve 
(compare Figs 1 and 3). Thus a protein with very similar proper-
ties to CNTF is present in optic nerve, but it could not be 
purified by this procedure, at least partly because it is apparently 
present at much lower concentrations in optic nerve than in 
sciatic nerve: in both type-2 astrocyte induction and neuronal 
survival assays, crude extracts of sciatic nerve had at least a 
IO-fold higher specific activity than crude extracts of optic nerve 
(data not shown). 
We showed previously that extracts of optic nerve from 3-4-
week-old rats have 20- to lOO-fold higher type-2-astrocyte-
inducing activity than extracts of optic nerve from I-week-old 
rats, when normalized for total protein concentration6 • When 
tested in the ciliary ganglion neuron survival assay, extracts of 
3-4-week-old nerves had a half-maximal effect at around 
IlLg ml- 1 of total protein whereas an extract of 4-5-day-old 
nerves had a half-maximal effect at around 25 ILg ml- I . 
Taken together, our results indicate that the type-2-astrocyte-
inducing protein in optic nerve is CNTF or a closely related 
protein. Several lines of evidence suggest that this protein is 
responsible for timing the onset of type-2 astrocyte differenti-
ation. (1) It greatly increases in the optic nerve between the first 
and third postnatal weeks6 , when type-2 astrocytes develop in 
vivo l6 (2) It acts on 0-2A progenitor cells isolated from E17-I8 
optic nerve6 , which is more than 10 days before these cells 
normally develop into type-2 astrocytesl6• This suggests that it 
is the increase in the CNTF-like protein rather than the onset 
of progenitor cell responsiveness to the protein that is respon-
sible for timing type-2 astrocyte differentiation in the developing 
optic nerve. (3) A similar molecule with type-2-astrocyte-
inducing activity is released by cultures of embryonic rat brain 
starting at the time type-2 astrocytes begin to develop; extracts 
of such cultures have much more of this activity and also 
promote ciliary ganglion neuron survival, while extracts pre-
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Fig. 1 The effects in vitro of sciatic nerve CNTF and optic nerve extract on GFAP expression in 0-2A progenitor cells (a and b) and on 
survival of ciliary ganglion neurons (c and d). 
Methods. Optic nerve cells from newborn (PO) Sprague-Oawley (S-O) rats were prepared as previously described '6 except that the dissociation 
was by 10 passages through a Pasteur pipette and the cells were washed in Oulbecco's modified Eagles' medium (OMEM) containing a variety 
of additives (modified from Bottenstein and Sat024 as previously described4 ) and O.S% fetal calf serum. The cells were cultured in the same 
medium on POlY-D-lysine-coated coverslips (about 8,000 cells per coverslip) with CNTF, or optic nerve extract or both (0, S ng ml-
' 
of CNTF 
and 8 fLg- l of extract) for 24 h. After fixation in 4% paraforma!<1.ehyde in phosphate-buffered saline for S min at room temperature, the cells 
were double-labelled with the A2BS monoclonal antibody'5 followed by goat anti-mouse immunoglobulin G (lg G) coupled to rhodamine 
(Cappel, 1: 100), and then (after postfixation in acid-alcohol) rabbit anti-GFAP serum26 (I: 1000) followed by sheep anti-rabbit IgG coupled 
to fluorescein (Wellcome, 1: lOO), as previously described". The cells were then mounted and examined in a fluorescence microscope to 
determine the proportion of 0-2A progenitor cells (recognized by their process-bearing morphology and staining with the A2BS antibodl,27) 
that expressed GFAP as described previousll. Ciliary ganglion neurons were prepared from 8-day-old chick embryos and cultured at a density 
of 1-2 x 103 cells well-I in multi well dishes (Costar, 16 mm) in FI4 medium with 10% horse serum, as previously described28, except that the 
culture dishes were coated with laminin (BRL, 2 fLg in SOO fLl per well) instead of heart-conditioned medium. The number of neurons initially 
plated per well was determined by counting the neurons 2 h after plating (_). After 24 h the number of surviving neurons was counted. Each 
point is the mean of at least 3 determinations (except for the two highest concentrations in Fig. 3b which were done in duplicate) and the 
bars represent the standard errors. Extracts of optic nerves from 3-4-week-old S-O rats were prepared as previously described6 • CNTF was 
prepared from adult Wistar rats by a modification of the method of Manthorpe and co-workers8,9, using OEAE ion-exchange chromatography 
and preparative SOS-PAGE. The purified CNTF gave a single silver-stained band when analysed by SOS-PAGE (see Fig. 2) or isoelectric 
focussing (not shown); partial amino acid sequence analysis of fragments of the purified protein has shown that the preparation contains a 
single protein. Both CNTF and optic nerve extract lost biological activity with freezing and thawing, which probably accounts for the small 
differences in the dose-response curves between a and c arid between band d. 
Fig.2 The type-2-astrocyte-inducing activity in optic nerve extract 
co-migrates with CNTF on SOS-PAGE 
Methods. CNTF and an extract from 3-4-week-old rat optic nerve 
were fractionated by electrophoresis on a IS% SOS polyacrylamide 
gel under non-reducing conditions29, along with standard relative 
molecular mass markers, as previously described6 . One track con-
taining crude optic nerve extract (7 fLg of protein) and another 
containing 20 ng of pure CNTF were silver-stained30 and are shown 
at the top of the figure. Another track from the same gel, containing 
crude optic nerve extract (lOO fLg of protein) was cut into 2.S mm 
slices and the protein in each slice was eluted in O.S ml OMEM 
containing O.S mg ml-
' 
bovine serum albumin3' , as previously 
described6 ; the protein eluted from each slice was tested (at a final 
dilution of I: 10) on cultures of PO optic nerve cells for GFAP-
inducing activity as described in Fig. 1. The arrowheads indicate 
the positions of standard markers (BRL), while the numbers over 
the arrowheads indicate the Mr (x 10-3) of the markers. 
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Fig. 3 The effects in vitro of CNTF prepared from optic nerve 
on GFAP expression in 0-2A progenitor cells (a) and on survival 
of ciliary ganglion neurons (b). 
Methods. CNTF was prepared from the optic nerves of 3-4-week-
old SoD rats and assayed as described in Fig. 1. Optic nerve cells 
were prepared as described in Fig. 1 or as previously described". 
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at least 50-fold less of both activities 17. 
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Studies on the development of optic nerve glial cells in culture 
have suggested that type-} astrocytes, the first glial cells to 
develop in the nervel6, play a crucial role in timing the start of 
oligodendrocyte differentiation4,18 by secreting platelet-derived 
growth factor (PDGF)15,19,20. The PDGF stimulates 0-2A pro-
genitor cells to proliferate l5,18 and drives an intrinsic clock in 
the progenitor cells that determines when they will differentiate 
into 0ligodendrocytes2o• There is evidence that type-} astrocytes 
in culture can also synthesize CNTF or a closely related 
molecule21 , which can initiate differentiation along the type-2 
astrocyte pathway17. Thus, by secreting PDGF and CNTF, type-
} astrocytes may regulate the timing of both olidogendrocyte 
and type-2 astrocyte development. The ability to reconstitute 
this timing in vitro 17,22 should facilitate the task of determining 
how the synthesis (or release) of these proteins is regulated. 
CNTF was originally identified10 and isolated8,9 as a factor 
that promotes the survival of postmitotic peripheral neurons in 
vitro. It has recently been shown that CNTF also affects the 
proliferation23 and differentiation (H,R. and U. Ernsberger, 
submitted) of E7 chick sympathetic neurons in vitro, These 
findings, together with the results presented here, suggest a role 
for CNTF in the control of both neuronal and glial differenti-
ation. 
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